Chronic hepatitis C in Swedish subjects receiving opiate substitution therapy—Factors associated with advanced fibrosis

Author： Jerkeman Anna   Westin Johan   Lagging Martin   Norkrans Gunnar   Lidman Christer   Frimand Jan   Simonsberg Christian   Kakko Johan   Widell Anders   Björkman Per  

Publisher： Informa Healthcare

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.46, Iss.5, 2014-05, pp. : 340-347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Commentary: triple therapy for patients with chronic hepatitis C and advanced fibrosis?

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1407-1408

John Wiley & Sons Inc

Access to resources Recommend Favorite

Commentary: triple therapy for patients with chronic hepatitis C and advanced fibrosis? Authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1408-1408

John Wiley & Sons Inc

Access to resources Recommend Favorite

Telaprevir‐based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 9, 2013-11 ,pp. : 1076-1085

John Wiley & Sons Inc

Access to resources Recommend Favorite

P169: The rate of hepatic decompensation of chronic Hepatitis C patients with advanced fibrosis after achieving sustained virological response

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 103-103

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of infections during interferon‐based treatment in patients with chronic hepatitis C virus infection and advanced hepatic fibrosis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 6, 2015-06 ,pp. : 1057-1064

John Wiley & Sons Inc

Access to resources Recommend Favorite